Daily non-political popular news in brief.

Study: Praying online helps cancer patients

01-03-2007 · EurekAlert!

Breast cancer patients who pray in online support groups can obtain mental health benefits, according to a new study conducted by the University of Wisconsin-Madison Center of Excellence in Cancer Communications Research that was funded by the National Cancer Institute.

Keywords: study, praying, online, cancer, patients, patient

« Previous | Next »

Similar news on "Study: Praying online helps cancer patients":

Cost control measures limit patient and physician choice in psychotropic medications
03-01-2007 · EurekAlert!
A new Brandeis University study published online in Clinical Therapeutics suggests that private health plans increasingly rely on escalating copayments to manage drug costs, as opposed to administrative controls. This makes treatment more expensive in many cases for patients, and may affect adherence to treatment, said lead author Dominic Hodgkin, associate professor at the Schneider Institute for Behavioral Health, Heller School for Social Policy and Management at Brandeis University.
Similar news · Read more »
Cancer patients, spouses report similar emotional distress, U-M study finds
09-20-2007 · EurekAlert!
A cancer diagnosis affects more than just the patient. A new study from researchers at the University of Michigan Comprehensive Cancer Center finds spouses report similar physical and emotional quality of life as the patient.
Similar news · Read more »
Success rates for prostate cancer depend on experience of surgeon
07-24-2007 · EurekAlert!
Surgeons performing operations to remove patients' prostate glands -- the primary treatment for prostate cancer -- go through a steep learning curve, according to a study published online July 24 in the Journal of the National Cancer Institute. As the surgeons gain more experience performing the operation, called a radical prostatectomy, the chance that patients' prostate cancer will reoccur goes down.
Similar news · Read more »
Anthracyclines improve survival in HER2-positive breast cancer patients
12-25-2007 · EurekAlert!
Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online Dec. 25 in the Journal of the National Cancer Institute.
Similar news · Read more »
Despite efforts, significant racial disparities in cancer therapy still exist
01-07-2008 · EurekAlert!
Black patients are significantly less likely than their white counterparts to receive therapy for various kinds of cancer, despite recent efforts to close gaps in treatment, according to a study by researchers at Yale School of Medicine published in the Jan. 7 online issue of the journal Cancer.
Similar news · Read more »
Gene therapy protocol at UCSD activates immune system in patients with leukemia
02-11-2008 · EurekAlert!
A research team at the Moores Cancer Center at University of California, San Diego reports that patients with chronic lymphocytic leukemia who were treated with a gene therapy protocol began making antibodies that reacted against their own leukemia cells. The study will be published on line the week of Feb. 11-15 in the online edition of the Proceedings of the National Academy of Science.
Similar news · Read more »
Kaiser Permanente -- Group Health study shows depression worsens HIV treatment
12-20-2007 · EurekAlert!
The largest study to examine the effect of depression on HIV treatment appears in the online edition of the Journal of Acquired Immune Deficiency Syndromes. The study by Kaiser Permanente and Group Health found depression significantly worsens a patient's adherence to highly active antiretroviral therapy and clinical measures but that effective antidepressant medication reverses this outcome. The study looked at 3,359 HIV-infected patients to measure the effects of depression -- with and without SSRIs.
Similar news · Read more »
Penn's Abramson Cancer Center part of major phase III study for myeloma
11-21-2007 · EurekAlert!
Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
Similar news · Read more »
Chemotherapy and tamoxifen reduce risk of second breast cancer
12-25-2007 · EurekAlert!
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online Dec. 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively.
Similar news · Read more »
Research shows survival benefit for leukemia patients treated with arsenic trioxide
06-04-2007 · EurekAlert!
Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide -- marketed as Trisenox -- significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.
Similar news · Read more »